Physician profile
Mark F Aaron
NPI 1306891262
$12,506.36
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $14.35 · 2022: $124 · 2023: $1,437 · 2024: $91.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732 · Travel and Lodging: $658 · Consulting Fee: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.73 |
| Travel and Lodging | $657.88 |
| Consulting Fee | $139.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10,791.30 | 2019-2024 | |
| Heartflow, INC. | $1,004.55 | 2023 | Ffrct |
| Abbott Laboratories | $299.68 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $187.24 | 2021-2023 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $73.04 | 2023-2024 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $38.85 | 2023 | Inpefa |
| Pfizer INC. | $31.86 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.46 | 2023 | Jardiance |
| Novo Nordisk INC | $21.87 | 2024 | Rybelsus, Ozempic |
| Nuwellis, INC. | $15.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Aaron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.